Generic doesn't mean Cheap

Generic doesn't mean Cheap

There is a common misconception in the world of pharmacy that “generic” means “cheap.”  While these two words have typically been synonymous with each other over the past 20 years, we are seeing more and more generic drugs creep into the range of $100, $250 and even as much as $1,000+/mo. 

The recent news about Turing Pharmaceuticals CEO Martin Shkreli raising the price of a 60-year old generic drug (daraprim) by 5000% is just one of the many cases where your company and your employees may be subjected to high cost generics.  

Our data and patented software shows this same practice is happening more and more with common drugs used for blood pressure, high cholesterol and diabetes and will mean billions in new costs to those paying the bill, namely self-funded organizations and their health plan members.  Our data has shown price variations on statins, ARB’s, oral hypoglycemics and other generic medications in excess of 2000%. 

So who’s profiting and who's to blame?  It depends on the case and can include parties other than the pharmaceutical company producing the medication.  As the medication goes through the supply chain, there is opportunity to touch and influence its price along the way. 

While “generic utilization” rates have been a telling statistic when looking at how your overall trend was doing, with the changes in the market, even companies touting 90+% generic utilization rates are exposed to much higher costs than they should be.  As your company develops a strategy with your consultant or broker to address the rising costs of your prescription benefit, having a specific strategy to combat this practice becomes more important by the day. 

Putting together a strategy that empowers your members to be active and savvy shoppers on the most predictable and repeated transaction in healthcare, pharmacy, is a great way to begin changing behavior and save money. Many people don't realize there are options out there and they really can save money. Whether it’s using a free drug price lookup tool like Medfisher.com or our proactive, patented and proven enterprise solution at Rx Savings Solutions --- choices are available. Consider pharmacy as a great segue into a greater healthcare consumerism strategy.

Khadijah Guy

Doctor of Occupational Therapy | Business Owner | Advocate for Older Adults Wishing to Age in Place

9 年

I agree with Taylor. Depending on the strength of the dosages of the medication, as well as getting the overall bang for your buck, you may be better off with one over the other. Personally, as a college student, I prefer holistic medicines when I am sick; I don't think that going cheaper is necessarily beneficial unless you are going cheap at a natural food or grocery store with a pharmacy inside. You want to take the most healthy approaches to taking care of your body, and medicine that just prolongs the sickness and does not immediately attack the virus within your body may not be a great solution after all. Maybe it is worth it to pay a little bit more to be sick just a little less longer!

回复
Tracy Burchette

Support Specialist

9 年

Generic is usually cheaper. I don't know that it works just the same. I have only seen a couple times, where generic was not cheaper.

回复
Taylor Rockhold

Apprentice Electrician

9 年

It seems like there are several names generic and name brand with the same ingredients, you just have to look and compare prices. Sometimes it is cheaper to buy the Prilosec rather than the Omeprazole depending on where you go.

回复
J. Raj Bali

Freelance Consultant at Self Employed

9 年

Hmm I don't know just because someone paid to put content out there doesn't mean that there isn't some grain of truth worth exploring behind it.

回复
Sissy Manesi

Marketing SkinCeuticals / L’oreal Dermatological Beauty

9 年

True story!!!!

回复

要查看或添加评论,请登录

Michael Rea的更多文章

  • Pain is the Only Real Incentive to Reduce Drug Prices

    Pain is the Only Real Incentive to Reduce Drug Prices

    On May 11, President Trump made a big deal out of his blueprint for reigning in drug prices. Though short on details…

    13 条评论
  • Fighting the Flu, and the Price of Treatment

    Fighting the Flu, and the Price of Treatment

    It has been the worst flu season since the 2009-2010 swine flu epidemic, which sickened 60 million Americans…

    2 条评论
  • Drug Price Hikes Ring in 2018

    Drug Price Hikes Ring in 2018

    Another year, another serious hike in drug prices. On January 1, 2018, a total of 1,305 prescription drugs increased in…

    46 条评论
  • If EpiPen? Suddenly Became Free It Still Wouldn’t Solve America’s Drug Price Crisis

    If EpiPen? Suddenly Became Free It Still Wouldn’t Solve America’s Drug Price Crisis

    Market elasticity in American pharmaceuticals is unlike any other industry anywhere in the world. If you buy a car…

    7 条评论
  • Drug Prices — We Are Not Helpless

    Drug Prices — We Are Not Helpless

    Over the past 10 months, the discussion about drug prices in the United States has never been so hotly debated. It has…

    43 条评论
  • THE Pharmacy Disruptor

    THE Pharmacy Disruptor

    The market on prescription drug pricing is volatile and literally is changing on a daily (if not more frequent) basis…

    3 条评论
  • Knowledge is Power for Saving on Prescription Drugs

    Knowledge is Power for Saving on Prescription Drugs

    Two weeks ago, we had the opportunity to help a member (we’ll call him Joe) with a tough choice on his hands. It was a…

    7 条评论
  • As pharmacy chain giants unite who's left with the bill?

    As pharmacy chain giants unite who's left with the bill?

    With the Walgreens, Rite Aid deal being confirmed, the market chatter is heating up once again. What does it all mean?…

    8 条评论
  • Drug Cost Debate from the Middle Seat

    Drug Cost Debate from the Middle Seat

    Yesterday, I had the opportunity to speak at a conference hosted by AHIP (America’s Health Insurance Plans) in Chicago.…

    10 条评论
  • You pay how much for drugs?

    You pay how much for drugs?

    I’ve never seen Americans so outraged by the news of the Turing Pharmaceuticals CEO, Martin Shkreli, raising the price…

    9 条评论

社区洞察

其他会员也浏览了